Nexien BioPharma, Inc.
NXEN
$0.0095
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.00K | 15.70K | 64.30K | 15.90K | 13.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.00K | 15.70K | 64.30K | 15.90K | 13.40K |
| Operating Income | -24.00K | -15.70K | -64.30K | -15.90K | -13.40K |
| Income Before Tax | -39.50K | -32.00K | -86.50K | -53.20K | -24.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.50K | -32.00K | -86.50K | -53.20K | -24.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.50K | -32.00K | -86.50K | -53.20K | -24.50K |
| EBIT | -24.00K | -15.70K | -64.30K | -15.90K | -13.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 70.77M | 70.47M | 68.72M | 66.38M | 65.11M |
| Average Diluted Shares Outstanding | 70.77M | 70.47M | 68.72M | 66.38M | 65.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |